InspireMD, Inc. has completed the full exercise of 12.9 million Series H warrants, converting primarily into pre-funded warrants, generating $17.9 million gross proceeds and $16.9 million after fees. The warrants were part of the private placement financing of up to $113.6 million announced in May 2023.
Company Information
Company
InspireMD
Location
6303 WATERFORD DISTRICT DRIVE
Miami, Florida, United States
About
InspireMD (NASDAQ: NSPR) is a commercial-stage medical device company dedicated to helping prevent stroke and save lives. We empower physicians and patients to choose carotid stenting without compromise—delivering smart design for stroke prevention through our proprietary MicroNet™ mesh technology. Uniquely engineered on the outside of the stent scaffold, our mesh is designed to reduce plaque prolapse and provide exceptional neurovascular protection during and after carotid procedures.
MiamiManufacturingBiotechnologyHealthcareHealth CareMedical Devicemedical devices